335428-53-0Relevant articles and documents
EP4 RECEPTOR AGONIST, COMPOSITIONS AND METHODS THEREOF
-
Page/Page column 40, (2010/02/14)
This invention relates to potent selective agonists of the EP4 subtype of prostaglandin E2 receptors, their use or a formulation thereof in the treatment of glaucoma and other conditions, which are related to elevated intraocular pressure in the eye of a patient. This invention further relates to the use of the compounds of this invention for mediating the bone modeling and remodeling processes of the osteoblasts and osteoclasts.